Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Genelux Q3 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate

Author: Benzinga Newsdesk | November 14, 2024 05:21pm
Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent.

Posted In: GNLX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist